We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Sarepta Therapeutics
SRPT
$1.77B
| $5.77M | 0.01% |
74,241
-4,101
| -5% | -$311K |
|
1352
Tandem Diabetes Care
TNDM
$1.29B
| $5.77M | 0.01% |
59,234
-3,884
| -6% | -$346K |
|
|
SUM
1353
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $5.76M | 0.01% |
168,202
-13,432
| -7% | -$423K |
|
|
FIRY
1354
Firy Inc
FIRY
$156M
| $5.76M | 0.01% |
+13,251
| New | +$4.73M |
|
1355
Northwest Bancshares
NWBI
$2.29B
| $5.75M | 0.01% |
421,824
-9,195
| -2% | -$130K |
|
|
EVBG
1356
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $5.75M | 0.01% |
42,246
-1,104
| -3% | -$138K |
|
1357
Dave & Buster's
PLAY
$351M
| $5.74M | 0.01% |
141,440
-4,963
| -3% | -$215K |
|
1358
NMI Holdings
NMIH
$3.31B
| $5.74M | 0.01% |
255,167
-13,614
| -5% | -$325K |
|
1359
Q2 Holdings
QTWO
$3.95B
| $5.74M | 0.01% |
55,908
+680
| +1% | +$68.1K |
|
1360
Century Communities
CCS
$1.96B
| $5.73M | 0.01% |
86,074
-11,738
| -12% | -$828K |
|
|
GWB
1361
DELISTED
Great Western Bancorp, Inc.
GWB
| $5.72M | 0.01% |
174,410
-10,543
| -6% | -$349K |
|
1362
La-Z-Boy
LZB
$1.63B
| $5.67M | 0.01% |
153,157
-2,485
| -2% | -$104K |
|
|
CSGS
1363
DELISTED
CSG Systems International
CSGS
| $5.66M | 0.01% |
119,853
+5,227
| +5% | +$238K |
|
|
CHNG
1364
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $5.65M | 0.01% |
245,044
-3,779
| -2% | -$86.9K |
|
|
CVSA
1365
Covista Inc
CVSA
$4.23B
| $5.63M | 0.01% |
157,969
-8,572
| -5% | -$322K |
|
|
AVNS
1366
DELISTED
Avanos Medical
AVNS
| $5.6M | 0.01% |
153,877
-1,930
| -1% | -$79.8K |
|
|
WIRE
1367
DELISTED
Encore Wire Corp
WIRE
| $5.6M | 0.01% |
73,840
-3,457
| -4% | -$266K |
|
1368
Ionis Pharmaceuticals
IONS
$9.06B
| $5.57M | 0.01% |
139,585
-4,821
| -3% | -$189K |
|
|
ADAM
1369
Adamas Trust
ADAM
$856M
| $5.55M | 0.01% |
310,698
-15,227
| -5% | -$277K |
|
1370
News Corp Class B
NWS
$18.3B
| $5.53M | 0.01% |
227,018
-10,989
| -5% | -$272K |
|
|
VBTX
1371
DELISTED
Veritex Holdings
VBTX
| $5.52M | 0.01% |
155,988
-10,317
| -6% | -$361K |
|
|
BPMC
1372
DELISTED
Blueprint Medicines
BPMC
| $5.51M | 0.01% |
62,677
+463
| +0.7% | +$42.4K |
|
1373
OSI Systems
OSIS
$3.91B
| $5.51M | 0.01% |
54,237
+5,089
| +10% | +$495K |
|
1374
Westamerica Bancorp
WABC
$1.37B
| $5.49M | 0.01% |
94,656
-3,072
| -3% | -$192K |
|
1375
Herbalife
HLF
$1.19B
| $5.49M | 0.01% |
104,152
+8,673
| +9% | +$431K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.